| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017111387 |
| P356 | DOI | 10.1007/S00262-005-0094-6 |
| P698 | PubMed publication ID | 16328383 |
| P50 | author | Lawrence S Lamb | Q38324930 |
| P2093 | author name string | Rebecca L O'Brien | |
| Michelle King | |||
| Stephanie Muga | |||
| Ronnie Neuberg | |||
| Paul F Meeh | |||
| Philip Buckhalts | |||
| P433 | issue | 9 | |
| P921 | main subject | acute leukemia | Q976388 |
| P304 | page(s) | 1072-1080 | |
| P577 | publication date | 2005-11-23 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Characterization of the gammadelta T cell response to acute leukemia | |
| P478 | volume | 55 |
| Q36759195 | Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate |
| Q37380386 | BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia |
| Q34946005 | CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells |
| Q37344951 | Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma |
| Q38217512 | Cytotoxic and regulatory properties of circulating Vδ1+ γδ T cells: a new player on the cell therapy field? |
| Q37120215 | Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications |
| Q30315866 | Different maturation cocktails provide dendritic cells with different chemoattractive properties |
| Q35587132 | Dynamics of Circulating γδ T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma. |
| Q38742867 | Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future. |
| Q55223108 | Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. |
| Q37587832 | Gammadelta T cells as immune effectors against high-grade gliomas |
| Q82235091 | Human Vδ1-T cells regulate immune responses by targeting autologous immature dendritic cells |
| Q39396311 | Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. |
| Q36908780 | Human gamma delta T cells: candidates for the development of immunotherapeutic strategies |
| Q90050645 | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation |
| Q52780147 | In-depth immunophenotyping of patients with glioblastoma multiforme: Impact of steroid treatment. |
| Q80196080 | Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation |
| Q37423895 | Oligoclonal expansion of TCR Vδ T cells may be a potential immune biomarker for clinical outcome of acute myeloid leukemia |
| Q37536445 | Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI |
| Q37676801 | Primary cutaneous B-cell lymphoma with abundant reactive gamma/delta T-cells within the skin lesion and peripheral blood |
| Q52763837 | Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease. |
| Q34585223 | Targeting γδ T cells for immunotherapy of HIV disease |
| Q91711253 | The Graft-Versus-Leukemia Effect in AML |
| Q37028734 | The evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation |
| Q36800215 | Tumor-infiltrating γδ T lymphocytes predict clinical outcome in human breast cancer |
| Q35634919 | γδ T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-αβ+/CD19+ lymphocytes |
Search more.